Taiwan’s Michael Ming-Chiao Lai, former vice president of Academia Sinica and researcher at its Institute of Molecular Biology, has been announced this year’s winner of the Nikkei Asia Prize in the category of Science, Technology and Innovation.Read more
US-based GE Healthcare announced this week that Taiwan’s United BioPharma Inc. (UBP) had selected GE Healthcare’s FlexFactory manufacturing platform for its new facility in Hsinchu, Taiwan, focusing on late-stage clinical and commercial production capacity of therapeutic monoclonal antibodies.Read more
Taiwan’s biotech and pharmaceutical industry was one of the first to be named in the original Tsai Administration’s 5+2 economic policy to transform the nation’s economic structure, and is viewed as the upcoming medical treatment trend that Taiwan cannot miss out on, said Johnsee Lee, the Honorary Chairman of Taiwan Bio Industry Organization (Taiwan BIO) during the Precision Medicine Industry Forum 2017 in Taipei, Wednesday.Read more
Chipscreen Biosciences Ltd. executives She Liang-ji, VP, Oncology Division, and Xin Fu, Medical Affairs Manager (left) meeting with GNTbm's President Alex Chen (right) in Taipei, Taiwan, in February this year.
GNT Biotech & Medicals Co., Ltd., (GNTbm) (TPEx: 7427) has announced that the anticancer drug Chidamide (HBI-8000), an epigenetic regulator developed by Chipscreen Biosciences Ltd., of Shenzhen, China, had received approval from the Taiwan Food and Drug Administration (TFDA) to begin a Phase III clinical trial in Taiwan for hormone receptor-positive, HER-2 negative late stage breast cancer.Read more
VP of New York-headquartered Corning Life Sciences, Richard Eglen, was in Taiwan recently to visit the Industrial Technology Research Institute (ITRI) and discuss possible partnerships around 3D cell culture technologies, of which the renowned glass and ceramics manufacturer has particular expertise in.Read more
A delegation from the Pharmaceutical Research and Manufacturers of America (PhRMA) made a recent visit to Taiwan and while here urged the government to pass laws that would better strengthen intellectual property protection for pharmaceuticals.Read more